Welcome to our dedicated page for Intuitive Surgical SEC filings (Ticker: ISRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Intuitive Surgical, Inc. (ISRG) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer headquartered in Sunnyvale, California, Intuitive uses these filings to report financial results, material events, and other information relevant to shareholders and regulators.
Among the key documents available are current reports on Form 8-K. Recent 8-K filings include items reporting quarterly financial results under Item 2.02, where Intuitive furnishes press releases detailing revenue, procedure growth on its da Vinci surgical systems and Ion endoluminal system, and changes in the installed base of systems. Another 8-K filing reports a change in the role of a senior executive under Item 5.02, illustrating how the company discloses updates related to its leadership structure.
Investors also use Intuitive’s SEC filings to follow information that may appear in annual reports on Form 10-K and quarterly reports on Form 10-Q, such as risk factor discussions, descriptions of the company’s business and technologies, and summaries of regulatory and market conditions affecting robotic-assisted surgery and minimally invasive care. While these specific forms are not reproduced in the provided excerpts, they are part of the broader filing set accessible through the SEC’s EDGAR system.
On Stock Titan, ISRG filings are paired with AI-powered summaries designed to explain the content and context of complex documents. These tools can help readers understand the significance of earnings releases, regulatory updates, or governance changes without reading every line of each filing. Users can also review filings that relate to financial reporting, such as exhibits containing press releases, and monitor how Intuitive communicates procedure trends, system placements, and other operational metrics to the market.
For investors researching Intuitive’s regulatory history, this page serves as a focused entry point to the company’s SEC disclosures, including 8-Ks that reference earnings announcements and other material developments.
Form 144 filing for Intuitive Surgical, Inc. (ISRG) shows a proposed sale of 29,360 common shares to be executed through Morgan Stanley Smith Barney on 08/29/2025, with an aggregate market value of $13,872,227.13. The shares were acquired the same day by stock option exercise and paid for in cash. The filing identifies prior sales during the past three months by Gary S. Guthart totaling 10,693 shares on 07/28/2025 for gross proceeds of $5,329,417.02. The filer affirms they are not aware of any undisclosed material adverse information and includes the standard Rule 10b5-1/trading-plan notice language.
Form 4 details insider activity at Intuitive Surgical (ISRG) on 28 Jul 2025 by Executive Chair Gary S. Guthart:
- Option exercise: 7,893 non-qualified options exercised at $59.4622.
- Open-market sales: Same 7,893 shares sold at a weighted-avg $498.64 (~$3.9 m). Two family trusts each sold 1,400 shares at ~$495, adding ≈$1.4 m.
- Charitable gift: 10,500 shares transferred to a Donor-Advised Fund (price reported $0).
After the transactions Guthart holds 13,187 shares directly and ~1.24 m shares indirectly through trusts, maintaining a large economic stake. All trades were executed under a Rule 10b5-1 plan expiring 28 Apr 2026, suggesting pre-scheduled diversification rather than a sudden sentiment shift.
Intuitive Surgical, Inc. (ISRG) – Form 144 filing: an unidentified insider has notified the SEC of a planned sale of 5,600 common shares through broker Charles Schwab. The shares were acquired via stock-option exercise on 12-03-2018. Proposed sale date is 28-Jul-2025.
The filing lists an aggregate market value of US$2.77 million, implying a price of roughly US$495 per share. Relative to the company’s 358.48 million shares outstanding, the disposition represents only about 0.0016 %, so it is immaterial to the public float. No prior sales were reported for the past three months and no Rule 10b5-1 trading plan date is supplied.
Form 144 indicates intent rather than completion; actual execution will depend on market conditions and the insider’s discretion. While insider selling can sometimes be viewed cautiously by investors, the small size versus total shares and lack of accompanying negative disclosures suggest limited market impact.
Intuitive Surgical (ISRG) EVP & Chief Medical Officer Myriam Curet filed a Form 4 for transactions dated 07/25/2025.
- Option exercise: 4,500 non-qualified options exercised at $242.3367 under the 2010 Incentive Award Plan.
- Share sale: The 4,500 resulting shares were immediately sold at $492.48, generating gross proceeds of roughly $2.2 million.
- Ownership: After both trades, Curet directly holds 353 common shares; net beneficial ownership is unchanged.
- Derivative position: 5,030 options remain outstanding.
- Transactions were executed under a Rule 10b5-1 trading plan that expires 13 Aug 2025.
The filing is routine, disclosing compliance with Section 16 insider-trading rules and does not alter control or capital structure.